Navigation Links
Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes
Date:2/10/2009

HAYWARD, Calif., Feb. 10 /PRNewswire/ -- Arete Therapeutics Inc. today announced the initiation of a Phase IIa clinical trial for AR9281, an orally- administered soluble epoxide hydrolase (s-EH) inhibitor being developed for the treatment of type 2 diabetes. S-EH is an enzyme involved in the metabolism of arachidonic acid, a key signaling molecule implicated in diabetes, hypertension and inflammatory disorders.

"Our AR9281 Phase II clinical trial program breaks new ground in two key areas. This is the first clinical study of a s-EH inhibitor in patients, and the first study designed to establish proof of concept that s-EH inhibition modulates glucose metabolism or blood pressure in patients with impaired glucose tolerance and hypertension," said James Sabry, M.D., Ph.D., President and Chief Executive Officer of Arete Therapeutics. "AR9281 has demonstrated an excellent safety profile and activity in multiple animal models of type 2 diabetes, and has the advantage of inhibiting a novel drug target that differentiates it from currently marketed diabetes medications. With this promising drug profile, AR9281 has the potential to provide safe and effective therapy for patients with type 2 diabetes either as monotherapy or in combination with existing treatment regimens."

The Phase IIa multicenter, double-blind, placebo-controlled study will enroll 150 pre-diabetic patients with impaired glucose tolerance, mild obesity and mild to moderate hypertension. All patients enrolled in the study will be treatment-naïve for type 2 diabetes medications. The trial will evaluate two schedules of AR9281 and placebo using a parallel design to determine the feasibility of twice-a-day dosing. Each patient will receive 28 days of treatment. Endpoints for the trial include safety, tolerability, reduction of blood pressure and various measures of glucose and lipid metabolism, with results expected in the first quarter of 2010.'/>"/>

SOURCE Arete Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CareTech Solutions Executive to Conduct Presentation on Creating a Healthy Revenue Cycle at AHIMA Convention and Exhibit
2. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
3. Arete Therapeutics Appoints Donald Santel to Board of Directors
4. CareTech Solutions Service Desk Equals Help Desk Plus
5. Nationally Recognized Diabetes Specialist Dr. Steven Edelman to Provide Educational Articles on Diabetes to MyCareTeam's Website Community
6. CareTech Solutions Named Best in KLAS for Extensive IT Outsourcing Services
7. EnovateIT Partners with CareTech Solutions to Create a Custom Product for Crittenton Hospital Medical Center, One of the Nation's Most Wired Hospitals
8. Prime Therapeutics Receives TIPPS Certification
9. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
10. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
11. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... TX (PRWEB) May 28, 2015 Ticket Down ... friendly soccer match between Mexico and Argentina in ... in the world will compete on the pitch at AT&T ... one another in an international friendly on Tuesday, September 8th ... most talented nations in the world including some of the ...
(Date:5/28/2015)... 2015 ZH Healthcare (ZH), a leading ... is releasing BlueEHS, the Electronic Health Solution, on the ... the benefit of all AWS users worldwide. , ... of its kind, Freemium, SaaS, Electronic Health Solution (EHS). ... with an integrated practice management system (PMS), e-Rx, lab ...
(Date:5/28/2015)... Dr. Paul Vitenas, one of the ... that the new Houston Surgery Center he recently opened ... of Ambulatory Surgery Facilities awarded this accreditation to Dr. ... According to Dr. Vitenas, the certificate was given to ... Class C ambulatory surgery facility. This certification means the ...
(Date:5/28/2015)... Beverly Hills, CA (PRWEB) May 28, 2015 ... a novel interactive keratoconus web application to ... Keratoconus has expanded in the last few years. This ... Even eye doctors are not aware of the nuances ... the Khanna Vision Institute, realized that websites can be ...
(Date:5/28/2015)... lifeIMAGE announced today that it has ... Cambia Health Solutions (Portland, Ore.), a nonprofit ... by creating a person-focused and economically sustainable system. lifeIMAGE, ... medical imaging, will use this financing to expand resources ... its network capabilities and implement the next phases of ...
Breaking Medicine News(10 mins):Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 3Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 2Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 3Health News:Dr. Paul Vitenas’ New Houston Surgery Center Receives AAAASF Accreditation 2Health News:Dr.Khanna Announced the Release of an Interactive Web Application for Keratoconus Treatment 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 4
... American Society of Pediatric Otolaryngology (ASPO) will hold its ... Combined Otolaryngology Spring Meetings (COSM) - a joint meeting ... During the ASPO meeting, hundreds of pieces of new ... will be presented focusing on children,s ear, nose, and ...
... Enterprise Development Center (EDC) took top awards ... New Jersey Technology Council. Endomedix, ... laurel "best life science company." The company recently ... chemical solutions composed of natural biomaterials. Surgeons can spray ...
... American College of Cardiology has designated the USF Health Center ... of Excellence in Education and Training. USF Health held ... downtown Tampa on March 30. The 90,000 square foot building ... and competence assessment under one roof, as well as significant ...
... Denise Mann HealthDay Reporter , MONDAY, April 9 ... risk for stroke than other types of cigarettes, especially for ... In the latest look at the hazards of menthols vs. ... who smoked menthols was more than twice that for regular-cigarette ...
... HealthDay Reporter , MONDAY, April 9 (HealthDay News) -- ... amounts of alcohol appear to increase their risk of developing ... large new study. The study, which followed more than ... (the equivalent of about one drink) consumed each day, the ...
... MONDAY, April 9 (HealthDay News) -- People,s average cholesterol ... countries, economies and ease of access to quality health ... data from thousands of patients with a history of ... 36 countries, including the United States. The analysis ...
Cached Medicine News:Health News:Scientific session and new research highlights 2Health News:Kudos for 3 NJIT Enterprise Development Center high-tech companies 2Health News:Kudos for 3 NJIT Enterprise Development Center high-tech companies 3Health News:American College of Cardiology cites new USF Simulation Center for Training Excellence 2Health News:Could Menthol Cigarettes Pose Even Higher Stroke Risk? 2Health News:Could Menthol Cigarettes Pose Even Higher Stroke Risk? 3Health News:Teen Drinking May Boost Odds of Precancerous Breast Changes 2Health News:Teen Drinking May Boost Odds of Precancerous Breast Changes 3Health News:Cholesterol Levels Vary Widely by Country: Study 2
(Date:5/28/2015)... , May 28, 2015  Service Strategies ... today announced that Fresenius Kabi, a global healthcare ... for infusion, transfusion and clinical nutrition, has achieved ... Performance (SCP) Standards for the seventh consecutive ... service effectiveness based upon a stringent set of ...
(Date:5/28/2015)... May 28, 2015 The global ... market with analysis and forecast of revenue. This market ... estimated to reach $1,177.8 million by 2019, at a ... Browse through the TOC of Mannequin-Based Simulation Market for ... with help of various tables and figures. ...
(Date:5/28/2015)... YORK, Pa. , May 28, 2015  Unilife Corporation ... its Chairman and CEO, Alan Shortall , will present ... New York at 3:00 p.m. ET on Monday, ... be broadcast over the Internet as a "live" listen only ... archive of the event will also be available for those ...
Breaking Medicine Technology:Fresenius Kabi Recognized by Service Strategies Corp. for Technical Service Excellence 2Fresenius Kabi Recognized by Service Strategies Corp. for Technical Service Excellence 3Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 2Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 3
... INDIANAPOLIS and PHOENIX, June 2 Dow AgroSciences, a ... DOW ), and World Wide Wheat (W3) LLC of ... and commercialization of advanced germplasm and traits in wheat. ... couple Dow AgroSciences, expertise in seeds and traits with W3,s ...
... TEL AVIV, Israel, June 2 ... newest aesthetic solution powered by 3rd generation,TriPollar RF ... been,published in the online Journal of the European ... conducted by Dr. Manuskiatti et al. at,the Mahidol ...
Cached Medicine Technology:Dow AgroSciences, World Wide Wheat Agree to Collaborate on Wheat 2Clinical Trial Results of Pollogen's TriPollar(TM) Radio Frequency Technology published in the Journal of the European Academy of Dermatology and Venereology 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: